A Phase 1 Trial to Evaluate CAP256V2LS in Healthy Adults
Clinical trial NCT04408963 · COMPLETED
Trial details
- NCT number
- NCT04408963
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2022-11-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.